CN Patent

CN117243959B — 治疗骨质疏松的方法和药物组合物

Assigned to Shandong University · Expires 2026-03-06 · 0y expired

What this patent protects

本发明提供了治疗骨质疏松的方法。本发明还提供了治疗骨质疏松的药物。

USPTO Abstract

本发明提供了治疗骨质疏松的方法。本发明还提供了治疗骨质疏松的药物。

Drugs covered by this patent

belumosudil-mesylate (BELUMOSUDIL MESYLATE)

Patent Metadata

Patent number: CN117243959B
Jurisdiction: CN
Classification: —
Expires: 2026-03-06
Drug substance claim: No
Drug product claim: No
Assignee: Shandong University
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.